U.S. Viral Vector And Plasmid DNA Manufacturing Market: The Surge in Cancer Therapies
The U.S. viral vector and plasmid DNA manufacturing market was valued at USD 2.2 billion in 2023 and is forecasted to reach USD 8.0 billion by 2030, [read full press release…]
